Harold Bernstein, MD
Glaucoma Specialist · Norfolk, VANPI 1215921994
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,876 of the $6,796 with a category attached, or 86.5%. It is spread thinly across 22 manufacturers, the largest accounting for just 18.6% — the pattern of someone who eats at a lot of different presentations.
Across 147 payments — averaging $46.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aerie Pharmaceuticals, Inc.$1K
- Alcon$1K
- AbbVie$1K
- Glaukos Corporation$842
- NEW World Medical,inc.$737
- Sight Sciences, Inc.$244
- plus $1K from 16 others
What the payments were for
- Consulting fees$82012%
- Food & beverage$5,87686%
- Education$1001%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aerie Pharmaceuticals, Inc. | 21 | $1,261 |
| Alcon | 25 | $1,253 |
| AbbVie(2 entities) | 36 | $1,233 |
| Glaukos Corporation | 6 | $842 |
| NEW World Medical,inc. | 6 | $737 |
| Sight Sciences, Inc. | 7 | $244 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 12 | $231 |
| Sun Pharmaceutical Industries Inc. | 10 | $217 |
| Bausch & Lomb Americas Inc. | 3 | $153 |
| Ocular Therapeutix, Inc. | 2 | $150 |
| Mallinckrodt Hospital Products Inc. | 2 | $124 |
| Novartis | 2 | $61 |
| Mallinckrodt Enterprises LLC | 2 | $48 |
| Rayner Intraocular Lenses Limited | 2 | $46 |
| Biotissue Holdings Inc. | 3 | $41 |
| Omeros Corporation | 2 | $30 |
| Carl Zeiss Meditec USA, Inc. | 1 | $29 |
| Oyster Point Pharma, Inc. | 1 | $23 |
| Amgen | 1 | $21 |
| Thea Pharma Inc. | 1 | $20 |
| Eyevance Pharmaceuticals LLC | 1 | $18 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Rocklatan$934
- Rhopressa$820
- Ahmed Glaucoma Valve$555
- Kahook Dual Blade$555
- iDose$470
- Hydrus Microstent$376
- Clearpath$283
- Streamline$283
- Via360$283
- Clareon$272
- XEN GLAUCOMA TREATMENT SYSTEM$222
- iStent Infinite$176
- iStent inject W$164
- DURYSTA$164
- Streamline Surgical System$150
- Clareon PanOptix Pro$144
- DEXTENZA$131
- MIEBO$113
- XIIDRA$113
- Unity$110
How this compares
Too few glaucoma specialist providers in Virginiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LumiganBimatoprost | 155 | $78,477 |
| CombiganBrimonidine Tartrate/Timolol | 38 | $15,084 |
| Travoprost | 72 | $13,628 |
| RhopressaNetarsudil Mesylate | 29 | $12,932 |
| RocklatanNetarsudil Mesylat/Latanoprost | 29 | $12,267 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 41 | $12,131 |
| Prednisolone Acetate | 224 | $8,648 |
| Latanoprost | 807 | $7,542 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 414 | $6,653 |
| VyzultaLatanoprostene Bunod | 21 | $6,425 |
| Alphagan PBrimonidine Tartrate | 13 | $5,827 |
| Brimonidine Tartrate | 227 | $5,586 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 32 | $4,533 |
| Methazolamide | 21 | $3,633 |
| Ketorolac Tromethamine | 82 | $3,050 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLumigan, Combigan, Alphagan P | $1,233 | $99,388206 claims |
| Aerie Pharmaceuticals, Inc.Rhopressa, Rocklatan | $1,261 | $25,19958 claims |
| AlconSimbrinza | $1,253 | $12,13141 claims |
| Bausch & Lomb Americas Inc.Vyzulta | $153 | $6,42521 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few glaucoma specialist providers in Virginiaon file to place this against a meaningful peer group, so we don't.
Other glaucoma specialist in Norfolk
- Elleny GutierrezVirginia Beach$5K
- Yonwook KimFairfax$4K
- Sina SabetAlexandria$2K
- Diana Salazar VegaFalls Church$2K
- Julia WhiteHampton$1K
- Scott WomackCharlottesville$777
- Parisa FarhiBlacksburg$88
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.